CETN2 and xeroderma pigmentosum: In combination with biochemical reconstitution assays, this method demonstrated that locating bulky lesions depends on a heterotrimeric factor composed of xeroderma pigmentosum group C (XPC; [23, 24]) one of two human RAD23 homologs (predominantly RAD23B; [25]) and centrin 2 (CETN2; [26–28]).